Oramed Pharmaceuticals
ORMP
#9215
Rank
โ‚ฌ0.15 B
Marketcap
3,74ย โ‚ฌ
Share price
1.96%
Change (1 day)
83.72%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): โ‚ฌ53.41 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of โ‚ฌ55.92 Million, an increase over its 2024 earnings that were of -โ‚ฌ13.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ53.41 M-4.5%
2025 โ‚ฌ55.92 M-513.21%
2024 -โ‚ฌ13.54 Million-311.47%
2023 โ‚ฌ6.4 M-119.45%
2022 -โ‚ฌ32.91 Million39.17%
2021 -โ‚ฌ23.65 Million73.93%
2020 -โ‚ฌ13.6 Million18.53%
2019 -โ‚ฌ11.47 Million-16.62%
2018 -โ‚ฌ13.76 Million38.32%
2017 -โ‚ฌ9.95 Million12.51%
2016 -โ‚ฌ8.84 Million25.01%
2015 -โ‚ฌ7.07 Million18.18%
2014 -โ‚ฌ5.99 Million39.72%
2013 -โ‚ฌ4.29 Million46.4%
2012 -โ‚ฌ2.93 Million128.32%
2011 -โ‚ฌ1.29 Million-51.47%
2010 -โ‚ฌ2.64 Million35.21%
2009 -โ‚ฌ1.96 Million
2007 -โ‚ฌ3.07 Million607.04%
2006 -โ‚ฌ0.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚ฌ20.85 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ6.43 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.46 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ54.91 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ31.33 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel